• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/18

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

18 Cards in this Set

  • Front
  • Back

First Line Tb Drugs

Isoniazid


Rifampin


Ethambutol


Pyrazinamide


Streptomycin

Isoniazid MOA

Prodrug requiring conversion by catalase peroxidase


Inhibit synthesis of mycolic acid by inhibiting fatty acid synthetase


Acts on intra and extracellular bacilli


Bactericidal for actively growing tubercle bacilli

Isoniazid USE

TB

Isoniazid ADVERSE EFFECTS

Hepatotoxicity, peripheral neuropathy, hemolysis inpatients with G6PD deficiency




Others: Pyridoxinedeficiency (VitB6) , SLE –like syndrome

Isoniazid DRUG INTERACTIONS

Antacids: Isoniazid (INH) absorption


Para-AminoSalicylic (PAS), Ethionamide: synergism

Isoniazid RESISTANCE

inactivating mutation in the mycobacterial enzyme catalase-peroxidase, which convertsisoniazid into its anti-mycobacterial form.

Rifampin MOA

Inhibitsinitiation of RNA synthesis by binding to DNA dependent RNA polymerasepreventingattachment of the enzyme to DNA, thus blocking initiation of RNA transcription.


Potent tuberculocidal drugand can penetrate phagocytic cells thereforecan kill intracellularorganisms

Rifampin USE

1.Gram (+) especially Staphylococcus (osteomyelitis and endocarditis)


2. Gram (-) N.meningitidis, N.gonorrhea, H. influenzae(type b) & Legionella


3. Chlamydia and some anaerobes

Rifampin ADVERSE EFFECTS

Yellow orange sweat, tears and urine


Hepatotoxicity

Rifampin DRUG INTERACTIONS

Itacts as a hepaticP450 enzyme inducer



Steroids, oral contraceptives, digoxin,sulfonylureas, warfarin, ketoconazole, chloramphenicol: decrease efficacy of these drugs

Pyrazinamide MOA

Is a prodrug; itmust be converted to its active form, pyrazinoicacid by the enzyme pyrazinamidase


Inhibitmycolic acidsynthesis by inhibiting fatty acid synthase 1


- Bacteriostatic or bactericidaldepending on the concentration and susceptibility of the organism.


-first-line drug used in conjunction with isoniazid and rifampin inshort-course



Pyrazinamide ADVERSE EFFECTS

Arthralgias (40%),hepatitis (1-5%), hyperuricemia(provoke acute gout)

Pyrazinamide RESISTANCE

dueto mutations in the pyrazinamidasegene,which result in the inability toconvert the prodrug intoits active form.

Streptomycin MOA

Itinhibits protein synthesis by combining irreversibly with the 30S subunit ofthe ribosomes, found typically in prokaryotes. - Specifically, it binds with the12S protein involved in the initiation of protein synthesis.


- penetrates poorly into cells & is active mainly against extracellular tubercle bacilli.

Streptomycin ADVERSE EFFECTS

ototoxicity, nephrotoxic

Ethambutol MOA

Itdisrupts arabinogalactan synthesis by inhibiting arabinosyl transferase.


- Disruption of the arabinogalactansynthesis leadsto increased permeability of the cell wall


-wellabsorbed from the GIT including CSF of patients with TB Meningitis

Ethambutol ADVERSE EFFECTS



retrobulbar (optic) neuritis (dose-related),hypersensitivity

Ethambutol RESISTANCE

from mutationsin the arabinosyltransferasegene